Devyser

Devyser is a company listed under the stock ticker DVYSR (SE).

View the org chart displaying its 13 main executives

Most searched biographies at Devyser

• Fredrik Alpsten, Chief Executive Officer
• Mia Arnhult, Chairman of the Board
• Lars Höckenström, Board Member

Popular executive movements at Devyser

• Thomas Eklund has joined the company as Director  (posted on May 16 2024).

Create your alert
to follow the executive moves at Devyser.

Devyser has 2,297 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).
• AbbVie has acquired Landos Biopharma (posted on May 25 2024).
• AltruBio has just announced a $225 Million fundraising (posted on May 24 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Devyser

• Devyser - Blog
• Devyser - Blog
• News and Press I Devyser

Social media about Devyser

• Devyser on Wikipedia, Google News & Yahoo Finance
• Devyser on LinkedIn, Twitter & YouTube

Contact by email its executives including Fredrik Alpsten

Call Devyser at +46 85...

View the org chart

Register to receive your alert

Report an error